propafenone has been researched along with Arrhythmia, Sinoatrial in 6 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to investigate the efficacy and safety of propafenone in the prevention of atrial fibrillation (AF) relapse after restoration of sinus rhythm." | 9.11 | Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion: a randomized, placebo-controlled study. ( Altinbas, A; Dogan, A; Ergene, O; Ergene, U; Gedikli, O; Kinay, O; Nazli, C; Ozaydin, M; Ucarci, Y, 2004) |
| "The development of a sustained-release formulation of propafenone allowed to reduce the wide fluctuations in plasma levels observed with the immediate release preparation, improving compliance and adherence to therapy, by simplifying the dosing regimen from 3 to 2 daily doses." | 6.48 | Atrial fibrillation and the pharmacological treatment: the role of propafenone. ( Molina, E; Sestito, A, 2012) |
| "The aim of this study was to investigate the efficacy and safety of propafenone in the prevention of atrial fibrillation (AF) relapse after restoration of sinus rhythm." | 5.11 | Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion: a randomized, placebo-controlled study. ( Altinbas, A; Dogan, A; Ergene, O; Ergene, U; Gedikli, O; Kinay, O; Nazli, C; Ozaydin, M; Ucarci, Y, 2004) |
| "The development of a sustained-release formulation of propafenone allowed to reduce the wide fluctuations in plasma levels observed with the immediate release preparation, improving compliance and adherence to therapy, by simplifying the dosing regimen from 3 to 2 daily doses." | 2.48 | Atrial fibrillation and the pharmacological treatment: the role of propafenone. ( Molina, E; Sestito, A, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sestito, A | 1 |
| Molina, E | 1 |
| Lee, JK | 1 |
| Klein, GJ | 1 |
| Krahn, AD | 1 |
| Yee, R | 1 |
| Zarnke, K | 1 |
| Simpson, C | 1 |
| Skanes, A | 1 |
| Dogan, A | 1 |
| Ergene, O | 1 |
| Nazli, C | 1 |
| Kinay, O | 1 |
| Altinbas, A | 1 |
| Ucarci, Y | 1 |
| Ergene, U | 1 |
| Ozaydin, M | 1 |
| Gedikli, O | 1 |
| Gulizia, M | 1 |
| Mangiameli, S | 1 |
| Orazi, S | 1 |
| Chiarandà, G | 1 |
| Piccione, G | 1 |
| Di Giovanni, N | 1 |
| Colletti, A | 1 |
| Pensabene, O | 1 |
| Lisi, F | 1 |
| Vasquez, L | 1 |
| Grammatico, A | 1 |
| Boriani, G | 1 |
| Vita, JA | 1 |
| Friedman, PL | 1 |
| Cantillon, C | 1 |
| Antman, EM | 1 |
1 review available for propafenone and Arrhythmia, Sinoatrial
| Article | Year |
|---|---|
Atrial fibrillation and the pharmacological treatment: the role of propafenone.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Delayed-Action Preparations | 2012 |
3 trials available for propafenone and Arrhythmia, Sinoatrial
2 other studies available for propafenone and Arrhythmia, Sinoatrial
| Article | Year |
|---|---|
Atrial fibrillation: rate control often better than rhythm control.
Topics: Adult; Aged; Amiodarone; Anticoagulants; Arrhythmia, Sinus; Atrial Fibrillation; Canada; Disopyramid | 2004 |
Efficacy of intravenous propafenone for the acute management of atrial fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmia, Sinus; Atrial Fibrillation; Double-Blind Method; Echocar | 1989 |